{"product_id":"pharmacovigilance-thao-doan-9780443118814","title":"Pharmacovigilance: A Practical Approach","description":"Written by multidisciplinary experts in the fields of pharmaceutical and patient safety, \u003ci\u003ePharmacovigilance: A Practical Approach, 2nd Edition\u003c\/i\u003e, provides a \u003cb\u003esuccinct, easy-to-digest overview\u003c\/b\u003e of an increasingly critical area of medical safety. From cover to cover, this concise resource offers \u003cb\u003eessential information for physicians and other health care professionals\u003c\/b\u003e, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.\u003cul\u003e\n\u003cli\u003ePresents \u003cb\u003evital, easy-to-read, cutting-edge information\u003c\/b\u003e on patient safety, the pharmacology regulatory landscape, and the current and future use of digital technologies.\u003c\/li\u003e\n\u003cli\u003eProvides \u003cb\u003eup-to-date coverage of hot topics in the field\u003c\/b\u003e, including pharmacodynamic and safety precision medicine, immunogenicity, vaccine hesitancy and safety, genetic toxicology, and adverse events.\u003c\/li\u003e\n\u003cli\u003eContains \u003cb\u003enew chapters\u003c\/b\u003e on pre-clinical safety assessment, pharmacogenetics, first-in human trials, product aggregate safety assessment, data monitoring committees, and more.\u003c\/li\u003e\n\u003cli\u003eOffers new and expanded coverage of pharmacovigilance in early pre-clinical drug development through post-marketing surveillance, as well as a \u003cb\u003eblueprint for training\u003c\/b\u003e future pharmacovigilance professionals.\u003c\/li\u003e\n\u003cli\u003eIncludes \u003cb\u003ereal-world case studies\u003c\/b\u003e to ensure content is relevant and applicable to everyday practice.\u003c\/li\u003e\n\u003cli\u003eDiscusses \u003cb\u003ea range of topics across disciplines\u003c\/b\u003e and how they relate to pharmacovigilance, including behavioral science, patient perspectives, and risk communication.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAn eBook version is included with purchase.\u003c\/b\u003e The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.\u003c\/li\u003e\n\u003c\/ul\u003e-Re-organized and expanded with 3 new sections and 9 new chapters covering pre-clinical safety assessment, pharmacogenetics, first-in human trials, product aggregate safety assessment, and data monitoring committees.-Up-to-date coverage of hot topics in the field, including pharmacodynamic and safety precision medicine, immunogenicity, vaccine hesitancy and safety, genetic toxicology, and adverse events.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Thao Doan\u003cbr\u003e\u003cb\u003eISBN-10:\u003c\/b\u003e 0443118817\u003cbr\u003e\u003cb\u003eISBN-13:\u003c\/b\u003e 9780443118814\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Elsevier\u003cbr\u003e\u003cb\u003eLanguage:\u003c\/b\u003e English\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 03\/24\/2025\u003cbr\u003e\u003cb\u003eFormat:\u003c\/b\u003e Paperback","brand":"Thao Doan","offers":[{"title":"Paperback","offer_id":46465678213375,"sku":"9780443118814","price":99.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/2982\/9887\/files\/img_cef1926d-683a-4e57-a5c0-2ebf2078e015.jpg?v=1736346962","url":"https:\/\/www.whiterainbookhouse.com\/products\/pharmacovigilance-thao-doan-9780443118814","provider":"WR Book House","version":"1.0","type":"link"}